Boxer Capital, Llc Rain Therapeutics Inc. (RAIN) insider trading activity

Boxer Capital, LLC is of Rain Therapeutics Inc.. Currently has a direct ownership of 1.15 Million shares of RAIN, which is worth approximately $0. The most recent transaction as insider was on May 22, 2023, when has been sold 995,000 shares (Common Stock) at a price of $1.25 per share, resulting in proceeds of $1,243,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.15M

0% 3M change

0% 12M change

Total Value Held $0

Boxer Capital, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 22 2023	SELL Open market or private sale	$1,243,750 $1.25 p/Share	995,000 Reduced 46.34%	1,152,212 Common Stock
Apr 27 2021	BUY Open market or private purchase	$17,425,000 $17.0 p/Share	1,025,000 Added 46.59%	1,175,000 Common Stock
Apr 23 2021	BUY Open market or private purchase	$2,389,500 $15.93 p/Share	150,000 Added 50.0%	150,000 Common Stock

Also insider at

MRTX

Mirati Therapeutics, Inc. Healthcare

ODTC

Odonate Therapeutics, Inc. Financial Services

> 10% Shareholder

ESPR

Esperion Therapeutics, Inc. Healthcare

> 10% Shareholder

SLDB

Solid Biosciences Inc. Healthcare

> 10% Shareholder

PAND

Pandion Therapeutics, Inc.

> 10% Shareholder

ITOS

iTeos Therapeutics, Inc. Healthcare

PMVP

PMV Pharmaceuticals, Inc. Healthcare

TYRA

Tyra Biosciences, Inc. Healthcare

TNGX

Tango Therapeutics, Inc. Healthcare

BCL